Shandong Weigao Group Medical Polymer Company Limited

SHWGF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenue$13,087$13,229$13,619$13,152
% Growth-1.1%-2.9%3.6%
Cost of Goods Sold$6,506$6,586$6,506$5,882
Gross Profit$6,581$6,643$7,306$7,353
% Margin50.3%50.2%53.6%55.9%
R&D Expenses$625$593$547$492
G&A Expenses$1,294$1,250$1,117$1,112
SG&A Expenses$3,629$3,832$3,544$3,773
Sales & Mktg Exp.$2,335$2,582$2,536$2,695
Other Operating Expenses-$60-$79-$125-$113
Operating Expenses$4,194$4,346$3,966$4,152
Operating Income$2,386$2,297$2,924$2,888
% Margin18.2%17.4%21.5%22%
Other Income/Exp. Net$168$72$461-$10
Pre-Tax Income$2,554$2,369$3,386$2,878
Tax Expense$391$308$436$420
Net Income$2,067$2,002$2,764$2,276
% Margin15.8%15.1%20.3%17.3%
EPS0.460.440.610.51
% Growth4.5%-27.9%19.6%
EPS Diluted0.450.440.610.5
Weighted Avg Shares Out4,5394,5504,5064,501
Weighted Avg Shares Out Dil4,5494,5404,5274,516
Supplemental Information
Interest Income$230$236$181$144
Interest Expense$250$273$191$140
Depreciation & Amortization$972$912$803$737
EBITDA$3,775$3,554$4,380$3,755
% Margin28.8%26.9%32.2%28.6%